These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of pancreaticobiliary secretion by loperamide in humans. Thimister PW; Hopman WP; van Roermund RF; Willems HL; Rosenbusch G; Woestenborghs R; Jansen JB Hepatology; 1997 Aug; 26(2):256-61. PubMed ID: 9252131 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Gullo L; Bolondi L; Priori P; Casanova P; Labò G Digestion; 1984; 29(4):209-13. PubMed ID: 6468768 [TBL] [Abstract][Full Text] [Related]
5. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [TBL] [Abstract][Full Text] [Related]
6. Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. Hopman WP; Kerstens PJ; Jansen JB; Rosenbusch G; Lamers CB Gastroenterology; 1985 Dec; 89(6):1242-7. PubMed ID: 3902553 [TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man. de Boer SY; Masclee AA; Jebbink MC; Schipper J; Jansen JB; Lamers CB JPEN J Parenter Enteral Nutr; 1992; 16(1):16-9. PubMed ID: 1738213 [TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057 [TBL] [Abstract][Full Text] [Related]
9. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. Hopman WP; Jansen JB; Rosenbusch G; Lamers CB Am J Clin Nutr; 1984 Mar; 39(3):356-9. PubMed ID: 6695835 [TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans. Shirohara H; Tabaru A; Otsuki M J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480 [TBL] [Abstract][Full Text] [Related]
14. Studies on neurotensin. I. Effects on gallbladder motility. Fujimura M Nihon Geka Hokan; 1989 Sep; 58(5):405-13. PubMed ID: 2642264 [TBL] [Abstract][Full Text] [Related]
15. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Kerstens PJ; Lamers CB; Jansen JB; de Jong AJ; Hessels M; Hafkenscheid JC Life Sci; 1985 Feb; 36(6):565-9. PubMed ID: 3968978 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholecystokinin-induced gallbladder contraction by atropine and pirenzepine in man. Yegen BC; Tankurt E; Gürmen N; Bayram M; Oktay S; Ulusoy NB Digestion; 1990; 45(3):176-80. PubMed ID: 2373273 [TBL] [Abstract][Full Text] [Related]
17. Role of cholecystokinin and the cholinergic system in intestinal stimulation of gallbladder contraction in man. Hopman WP; Jansen JB; Rosenbusch G; Lamers CB Hepatology; 1990 Feb; 11(2):261-5. PubMed ID: 2307405 [TBL] [Abstract][Full Text] [Related]
18. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man. Douglas BR; Jebbink MC; Tjon a Tham RT; Jansen JB; Lamers CB Eur J Pharmacol; 1989 Jul; 166(2):307-9. PubMed ID: 2792196 [TBL] [Abstract][Full Text] [Related]